Biopharma design solutions
A regional leader in preclinical R&D with a diversified project portfolio operated by exceptional researchers and industry professionals.
We apply three platforms to discover new drugs:
- Miniprotein-based biopharmaceuticals platform. It employs a peptide megalibrary with more than a million candidates from which promising leads can be selected and developed for specific targets
- Drug repositioning (fixed-dose combinations, FDC) to create new, safe and effective therapeutic options using drugs already on the market
- Cell and gene therapy (CGT) allows us to utilize cutting-edge scientific techniques to to improve or extend the life of millions of people.
We deliver custom-made cell lines, develop and provide bioassays for your research and development. The exclusivity we provide ensures an increased competitive advantage over your competitors.
Our in house developed and in-licensed projects are managed applying a state of the art project management approach for discovery and pre-clinical development. We rely on the broad experience of our scientists in a wide range of in vitro and in vivo methodologies.
We are constantly looking for word class talent, join us if you want to work in an agile environment to stay ahead of the game in healthcare.
